コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ontain extracellular Abeta amyloid deposits (senile plaques).
2 erebral vasculature and, less frequently, in senile plaques.
3 e recruited from the blood and accumulate in senile plaques.
4 mponent of Alzheimer disease (AD)-associated senile plaques.
5 ng the deposition of amyloid beta (Abeta) in senile plaques.
6 kill neurons and eventually form deposits of senile plaques.
7 oid fibrils that accumulate at the center of senile plaques.
8 ated to contribute to amyloid depositions in senile plaques.
9 are observed associated with the majority of senile plaques.
10 aggregates into the fibrils that deposit in senile plaques.
11 es (microglia) that accumulate in and around senile plaques.
12 ggregates in the extracellular space to form senile plaques.
13 ocalization with neurofibrillary tangles and senile plaques.
14 ed most strikingly as the amyloid fibrils of senile plaques.
15 zheimer disease: neurofibrillary tangles and senile plaques.
16 s was seen for total senile plaques or cored senile plaques.
17 and formation of neurofibrillary tangles and senile plaques.
18 gical hallmarks of Alzheimer's disease (AD): senile plaques.
19 nt properties of beta-amyloid present in the senile plaques.
20 and microglial cells surrounding individual senile plaques.
21 otion, deposition, and/or persistence of the senile plaques.
22 clusters of reactive microglia that surround senile plaques.
23 -immunoreactive neurites are also present in senile plaques.
24 f the scavenger receptor in association with senile plaques.
25 beta) peptides accumulate extracellularly in senile plaques.
26 ranscription factor that is activated around senile plaques.
27 y disrupted in the cortex, specifically near senile plaques.
28 nd have been found colocalized with Abeta in senile plaques.
29 e presynapses engulf amyloid-beta-containing senile plaques.
30 tease thrombin is neurotoxic and found in AD senile plaques.
31 o generate the beta-amyloid (Abeta) found in senile plaques.
32 oid-beta (Abeta), the principal component of senile plaques.
33 apy on morphological changes associated with senile plaques.
34 enchyma and its subsequent accumulation into senile plaques.
35 ed against the Abeta peptide, a component of senile plaques.
36 than the Abeta(1-42) peptide which forms AD senile plaques.
37 phological abnormalities precede and lead to senile plaques.
38 ptide (A beta) is the primary constituent of senile plaques, a defining feature of Alzheimer's diseas
39 eptide (Abeta) is the primary constituent of senile plaques, a defining feature of Alzheimer's diseas
41 Amyloid-beta peptide (Abeta) accumulation in senile plaques, a pathological hallmark of Alzheimer's d
44 gical effect were present, we also looked at senile plaque and neurofibrillary tangle densities in th
45 d beta-protein, the principal constituent of senile plaques and a cytotoxic fragment involved in the
46 position of amyloid-beta (Abeta) peptides in senile plaques and accumulation of hyperphosphorylated t
49 use models, caffeine significantly decreases senile plaques and amyloid beta (Abeta) levels while als
50 ression found in microglia accumulating near senile plaques and apposing CB(1) cannabinoid receptor-p
51 rodents, and because NHPs naturally develop senile plaques and CAA with age, NHPs appear to be impor
52 main constituent of amyloid fibrils found in senile plaques and cerebral vessels in Alzheimer's disea
53 ide (A beta), the major protein component in senile plaques and cerebrovascular amyloidosis in the br
54 sive accumulation of beta-amyloid (Abeta) in senile plaques and in the cerebral vasculature is the ha
55 sive accumulation of beta-amyloid (Abeta) in senile plaques and in the cerebral vasculature is the ha
56 of fibrillar amyloid-beta protein (Abeta) in senile plaques and in the walls of cerebral blood vessel
57 tracellular amyloid-beta (Abeta), evident as senile plaques and intracellular neurofibrillary tangles
58 a are found to be intimately associated with senile plaques and may play a central role in mediating
60 aggregates that are associated with amyloid senile plaques and neurofibrillary tangles in AD brains.
61 acterized pathologically by the abundance of senile plaques and neurofibrillary tangles in the brain.
62 d larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocor
63 mbrane attachment, and (or) association with senile plaques and neurofibrillary tangles is a major fe
65 f neocortical Alzheimer disease lesions (ie, senile plaques and neurofibrillary tangles) as assessed
66 id and tau proteins, which aggregate to form senile plaques and neurofibrillary tangles, respectively
68 peptides) and Tau are the main components of senile plaques and neurofibrillary tangles, the two hist
69 nd the lesions that characterize the disease-senile plaques and neurofibrillary tangles-ramify system
70 hat redox-active iron is associated with the senile plaques and neurofibrillary tangles-the pathologi
79 cterized by the presence of amyloid-positive senile plaques and tau-positive neurofibrillary tangles.
80 11-40/42 is generated prior to deposition in senile plaques and that N-terminally truncated Abeta pep
81 abundant deposition of ss-amyloid (Ass) 1-42 senile plaques and the formation of neurofibrillary tang
82 ary tangles and neuronal loss, the number of senile plaques and the percentage of the superior tempor
84 e had developed profuse Abeta-immunoreactive senile plaques and vascular deposits, some of which were
87 densities of neurofibrillary tangles, total senile plaques, and cored senile plaques in subjects wit
88 ease (AD), we counted the number of neurons, senile plaques, and neurofibrillary tangles in a high-or
90 ns of beta-amyloid, a major component of the senile plaques, and of the excitatory amino acid glutama
97 in, large dystrophic neurites in a subset of senile plaques are conspicuously labeled with APLP1 and
101 ric forms of Abeta-42 rather than fibrils or senile plaques are the key pathological substrates.
102 on, growth, and maturation of brain amyloid "senile" plaques are essential pathological processes in
104 indicate that HGF/SF may be increased within senile plaques as a function of the gliosis and microgli
105 ity was present in the neuritic component of senile plaques as well as in neurofibrillary tangles.
106 show widespread neurofibrillary tangles and senile plaques as well as Lewy body formation and nigral
107 e (A beta), the primary protein component in senile plaques associated with Alzheimer's disease (AD),
108 protein (AbetaP) is the major constituent of senile plaques associated with Alzheimer's disease (AD).
109 (Abeta) is the primary protein component of senile plaques associated with Alzheimer's disease and h
111 osis had a greater neurofibrillary tangle or senile plaque burden than subjects with Alzheimer diseas
112 isease, Abeta fibrils constitute the core of senile plaques, but Abeta protofibrils may represent the
113 ected symmetrically; in 72%, there were only senile plaques, but there were both senile plaques and n
114 ocannabinoid signalling, particularly around senile plaques, can exacerbate synaptic failure in Alzhe
115 ta-amyloid (Abeta), which accumulates in the senile plaques characteristic for Alzheimer's disease.
116 ides (Abeta) are the major components of the senile plaques characteristic of Alzheimer's disease.
119 Alzheimer's disease is characterized by senile plaques composed of polymeric fibrils of beta amy
122 Alzheimer's patients contains extracellular senile plaques composed primarily of deposits of fibrill
123 gical hallmark of Alzheimer's disease is the senile plaque, composed of beta-amyloid fibrils, microgl
126 tures of Alzheimer's disease (AD) brains are senile plaques, comprising beta-amyloid (Abeta) peptides
127 lzheimer's disease (AD) is the deposition of senile plaques consisting largely of a peptide known as
128 n-negative neurites that are associated with senile plaques containing amyloid beta peptides of the 1
129 glia are immune system cells associated with senile plaques containing beta-amyloid (Abeta) in Alzhei
130 gical hallmark of Alzheimer's disease is the senile plaque, containing beta-amyloid fibrils, microgli
133 ied Abeta-42 (AN-1792) has demonstrated that senile plaque disruption occurred in immunized humans as
135 ufficient neurofibrillary tangles (NFTs) and senile plaques for the neuropathological diagnosis of AD
136 duction are predicted to result in decreased senile plaque formation, a proposed contributor to neuro
137 of AEP from 5XFAD or APP/PS1 mice decreases senile plaque formation, ameliorates synapse loss, eleva
141 a), one of the primary protein components of senile plaques found in Alzheimer disease, is believed t
142 id-beta (Abeta) the primary component of the senile plaques found in Alzheimer's disease (AD) is gene
145 release amyloid beta, the main component in senile plaques found in the brains of patients with Alzh
148 ly high Cu(2+) ion concentrations present in senile plaques has provoked a substantial interest in th
150 beta), which are the primary constituents of senile plaques, have been shown to activate tyrosine kin
152 at higher levels than the 42-mer (Abeta42), senile plaque in diseased brains is composed primarily o
154 roduct of APP proteolysis and a component of senile plaques in AD, were detected in RGCs by immunohis
161 ave differential effects on the formation of senile plaques in Alzheimer's brains and that RTN3 has a
163 Accumulation of amyloid-beta (Abeta) into senile plaques in Alzheimer's disease (AD) is a hallmark
165 d that amyloid Abeta, the major component of senile plaques in Alzheimer's disease (AD), binds Cu wit
166 Amyloid-beta (Abeta), major constituent of senile plaques in Alzheimer's disease (AD), is generated
167 e generation of Abeta, the main component of senile plaques in Alzheimer's disease (AD), is precluded
168 HspB1, an sHsp commonly associated with senile plaques in Alzheimer's disease (AD), prevents the
169 eta peptide deposits, the major component of senile plaques in Alzheimer's disease (AD), was mapped i
172 (Abeta) is the primary protein component of senile plaques in Alzheimer's disease and is believed to
173 (A beta) is the primary protein component of senile plaques in Alzheimer's disease and is believed to
174 -protein (A beta) is the main constituent of senile plaques in Alzheimer's disease and is derived by
175 subjects and found that synapse loss around senile plaques in Alzheimer's disease correlates with th
178 Amyloid-beta, the primary constituent of senile plaques in Alzheimer's disease, is hypothesized t
185 1-42) peptide, which is a major component of senile plaques in Alzheimer's, can directly induce incre
187 noreactivity in astroglial cells surrounding senile plaques in brain tissue sections from authentic A
189 yloid (Abeta) peptides that are deposited in senile plaques in brains of aged individuals and patient
191 ss glutamate and occur in close proximity to senile plaques in human Alzheimer's disease (AD) brain.
192 42 is the major Abeta species in parenchymal senile plaques in most Alzheimer's diseased brains in sp
193 d monoacylglycerol lipase, begin to surround senile plaques in probable Alzheimer's disease (Braak st
194 ary tangles, total senile plaques, and cored senile plaques in subjects with psychosis vs subjects wi
195 disease, the formation of Abeta fibrils and senile plaques in the brain initiates a cascade of event
196 eposition of amyloid beta peptide (Abeta) as senile plaques in the brain is the pathological hallmark
197 tomography have provided measures of amyloid senile plaques in the brain of demented patients and pat
199 se (AD) is characterized by large numbers of senile plaques in the brain that consist of fibrillar ag
200 ition of the beta-amyloid (Abeta) peptide in senile plaques in the brain, leading to neuronal dysfunc
208 ides (Abeta40 and 42) that aggregate to form senile plaques in the brains of patients with Alzheimer'
211 position of amyloid-beta (Abeta) peptides in senile plaques in the hippocampus and cerebral cortex.
214 Abeta and Abeta(x-42/43) but not Abeta(x-40) senile plaques in the superior temporal sulcus when comp
215 er scanning imaging of thioflavine S-stained senile plaques in the Tg2576 transgenic mouse model of A
217 ining in the amyloid deposits of dense-core (senile) plaques, in the amyloid angiopathy surrounding d
218 beta-amyloid (Abeta), the main component of senile plaques, induced a significant decrease in dynami
219 beta-amyloid (Abeta), the main component of senile plaques, induced a significant decrease in dynami
220 beta-amyloid (Abeta), the main component of senile plaques, induces abnormal posttranslational proce
221 er disease-affected brains mainly consist of senile plaques, inflammation stigmata, and oxidative str
222 Amyloid-beta peptide (Abeta) aggregate in senile plaque is a key characteristic of Alzheimer's dis
223 ion of inflammatory microglia in Alzheimer's senile plaques is a hallmark of the innate response to b
224 beta (Abeta) peptide deposition as fibrillar senile plaques is a key element in the pathology of Alzh
225 e main component of Alzheimer's disease (AD) senile plaques is amyloid-beta peptide (Abeta), a proteo
226 rogression from oligomers to fibrils forming senile plaques is currently considered a protective mech
227 which is implicated in AD by its presence in senile plaques, its transport of Abeta across the blood-
229 s for the burden of neurofibrillary tangles, senile plaques, Lewy bodies (LBs), and Lewy neurites (LN
230 beta-amyloid (Abeta) accumulation, including senile plaque-like structures in the hippocampus and tem
233 ized by two histopathological hallmarks: the senile plaques made of amyloid-beta (Abeta) peptide fibr
234 post mortem by the presence of extracellular senile plaques, made primarily of aggregation of amyloid
238 racterized by a build-up of Abeta peptide as senile plaques, neurodegeneration, and memory loss.
239 pathways may be the key to understanding how senile plaques, neurofibrillary tangles and apoptosis ar
240 oid-beta (Ass) peptide forming extracellular senile plaques, neurofibrillary tangles made of hyperpho
241 characterized by regional concentrations of senile plaques, neurofibrillary tangles, and extensive n
243 e neurodegenerative disease characterized by senile plaques, neurofibrillary tangles, dystrophic neur
246 als, two important biomarkers present in the senile plaques of Alzheimer's disease (AD) brain, has be
247 eta) peptides at a high concentration in the senile plaques of Alzheimer's disease (AD) patients and
250 Cu(2+) ions are found concentrated within senile plaques of Alzheimer's disease patients directly
253 ase (AD) is characterized by the presence of senile plaques of amyloid-beta (Abeta) peptides derived
254 ane attack complex (MAC) are co-localized in senile plaques of brains from Alzheimer's disease (AD) p
256 ince Abeta is found as insoluble deposits in senile plaques of the AD brain, and the Abeta peptide ca
259 (Abeta) peptides are the major components of senile plaques, one of the main pathological hallmarks o
260 erlapping 40%-50% reduction in the number of senile plaques, one of the pathological hallmarks of AD.
263 er AMY plaques are non-amyloid precursors to senile plaques or if they represent an independent type
264 one to the development of AD or to increased senile plaques or neurofibrillary tangle formation in th
266 his is caused by fibrillar deposits known as senile plaques or soluble oligomeric forms of amyloid be
267 Given the elevated concentration of Cu in senile plaques, our results suggest that Cu interactions
270 logical hallmark of Alzheimer disease is the senile plaque principally composed of tightly aggregated
271 umulation of beta-amyloid (Abeta) peptide as senile plaques, progressive neurodegeneration, and memor
272 at some have speculated may be precursors to senile plaques remains to be determined, as is the relat
273 n (A beta), the principal constituent of the senile plaques seen in Alzheimer's disease (AD), is deri
274 sing amyloid precursor protein (APP) develop senile plaques similar to those found in Alzheimer's dis
276 (AD) include therapies designed to decrease senile plaque (SP) formation and/or promote clearance of
280 e (AD) is characterized by the deposition of senile plaques (SPs) and neurofibrillary tangles (NFTs)
281 estration of RNA in Alzheimer's disease (AD) senile plaques (SPs) and the production of intraneuronal
282 sition of neurofibrillary tangles (NFTs) and senile plaques (SPs) has been characterized extensively
284 paratus, neurofibrillary tangles (NFTs), and senile plaques (SPs) in the hippocampus of six cases of
285 position of amyloid-beta peptides (Abeta) in senile plaques (SPs) is a central pathological feature o
286 he pathogenesis of Alzheimer's disease (AD), senile plaques (SPs), and neurofibrillary tangles (NFTs)
287 l lobar degeneration, including beta-amyloid senile plaques, tau neurofibrillary tangles, and fused i
288 (AD), and the deposition of Abeta within the senile plaques that are a hallmark of AD is thought to b
289 rks is the accumulation of the extracellular senile plaques that are mainly composed of amyloid beta
290 PECT imaging agents for the detection of the senile plaques, the development of bi-functional molecul
292 beta) aggregates are the main constituent of senile plaques, the histological hallmark of Alzheimer's
293 Although microglia are an integral part of senile plaques, their role in the development of Alzheim
294 eposition of the same peptide in the form of senile plaques, there is considerable interest in the re
295 f fibrillar amyloid beta proteins (Abeta) in senile plaques throughout the cerebral cortex are consis
296 l hallmark of AD is the presence of numerous senile plaques throughout the hippocampus and cerebral c
297 Alzheimer disease (AD) is characterized by senile plaques, which are mainly composed of beta amyloi
298 rains shows the presence of large numbers of senile plaques, whose major component is the beta-amyloi
300 a protofibrils accumulate at the exterior of senile plaques, yet the protofibril-fibril interplay is